Study on Motion Management of Pancreatic Cancer Treated by CyberKnife

PurposeWe investigated the movement characteristics of pancreas and the clinical accuracy of tracking pancreas with the Synchrony Respiratory Tracking System (SRTS) during the CyberKnife treatment. These data provide a clinical data basis for the expansion margins of pancreatic tumor target.Methods...

Full description

Bibliographic Details
Main Authors: Shenghua Jing, Changchen Jiang, Xiaoqin Ji, Xiangnan Qiu, Jing Li, Xiangdong Sun, Xixu Zhu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-12-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.767832/full
_version_ 1818844166331826176
author Shenghua Jing
Changchen Jiang
Xiaoqin Ji
Xiangnan Qiu
Jing Li
Xiangdong Sun
Xixu Zhu
author_facet Shenghua Jing
Changchen Jiang
Xiaoqin Ji
Xiangnan Qiu
Jing Li
Xiangdong Sun
Xixu Zhu
author_sort Shenghua Jing
collection DOAJ
description PurposeWe investigated the movement characteristics of pancreas and the clinical accuracy of tracking pancreas with the Synchrony Respiratory Tracking System (SRTS) during the CyberKnife treatment. These data provide a clinical data basis for the expansion margins of pancreatic tumor target.Methods and MaterialsForty-two patients with pancreatic cancer treated by CyberKnife were retrospectively studied. The pancreatic displacement calculated from the x-ray images collected during the time interval between two consecutive movements constituted a data set.ResultsThe total mean motion amplitudes and standard deviations of pancreatic tumors in SI, LR, AP, and radial directions were 3.66 ± 1.71 mm, 0.97 ± 0.62 mm, 1.52 ± 1.02 mm, and 1.36 ± 0.49 mm, respectively. The overall mean correlation errors and standard deviations were 0.82 ± 0.46 mm, 0.47 ± 0.33 mm, 0.41 ± 0.24 mm, and 0.98 ± 0.37 mm, respectively. The overall mean prediction errors and standard deviations were 0.57 ± 0.14 mm, 0.62 ± 0.28 mm, 0.39 ± 0.17 mm, and 1.58 ± 0.36 mm, respectively. The correlation errors and prediction errors of pancreatic tumors at different anatomical positions in SI, LR, and AP directions were statistically significant (p < 0.05).ConclusionsThe tumor motion amplitude, the tumor location, and the treatment time are the main factors affecting the tracking accuracy. The pancreatic tumors at different anatomical locations should be treated differently to ensure sufficient dose coverage of the pancreatic target area.
first_indexed 2024-12-19T05:09:26Z
format Article
id doaj.art-a04956752a444bc5a54ef18f9a44caee
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-19T05:09:26Z
publishDate 2021-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-a04956752a444bc5a54ef18f9a44caee2022-12-21T20:34:51ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-12-011110.3389/fonc.2021.767832767832Study on Motion Management of Pancreatic Cancer Treated by CyberKnifeShenghua JingChangchen JiangXiaoqin JiXiangnan QiuJing LiXiangdong SunXixu ZhuPurposeWe investigated the movement characteristics of pancreas and the clinical accuracy of tracking pancreas with the Synchrony Respiratory Tracking System (SRTS) during the CyberKnife treatment. These data provide a clinical data basis for the expansion margins of pancreatic tumor target.Methods and MaterialsForty-two patients with pancreatic cancer treated by CyberKnife were retrospectively studied. The pancreatic displacement calculated from the x-ray images collected during the time interval between two consecutive movements constituted a data set.ResultsThe total mean motion amplitudes and standard deviations of pancreatic tumors in SI, LR, AP, and radial directions were 3.66 ± 1.71 mm, 0.97 ± 0.62 mm, 1.52 ± 1.02 mm, and 1.36 ± 0.49 mm, respectively. The overall mean correlation errors and standard deviations were 0.82 ± 0.46 mm, 0.47 ± 0.33 mm, 0.41 ± 0.24 mm, and 0.98 ± 0.37 mm, respectively. The overall mean prediction errors and standard deviations were 0.57 ± 0.14 mm, 0.62 ± 0.28 mm, 0.39 ± 0.17 mm, and 1.58 ± 0.36 mm, respectively. The correlation errors and prediction errors of pancreatic tumors at different anatomical positions in SI, LR, and AP directions were statistically significant (p < 0.05).ConclusionsThe tumor motion amplitude, the tumor location, and the treatment time are the main factors affecting the tracking accuracy. The pancreatic tumors at different anatomical locations should be treated differently to ensure sufficient dose coverage of the pancreatic target area.https://www.frontiersin.org/articles/10.3389/fonc.2021.767832/fullCyberKnifeexpansion marginpancreatic cancerSRTStumor motion management
spellingShingle Shenghua Jing
Changchen Jiang
Xiaoqin Ji
Xiangnan Qiu
Jing Li
Xiangdong Sun
Xixu Zhu
Study on Motion Management of Pancreatic Cancer Treated by CyberKnife
Frontiers in Oncology
CyberKnife
expansion margin
pancreatic cancer
SRTS
tumor motion management
title Study on Motion Management of Pancreatic Cancer Treated by CyberKnife
title_full Study on Motion Management of Pancreatic Cancer Treated by CyberKnife
title_fullStr Study on Motion Management of Pancreatic Cancer Treated by CyberKnife
title_full_unstemmed Study on Motion Management of Pancreatic Cancer Treated by CyberKnife
title_short Study on Motion Management of Pancreatic Cancer Treated by CyberKnife
title_sort study on motion management of pancreatic cancer treated by cyberknife
topic CyberKnife
expansion margin
pancreatic cancer
SRTS
tumor motion management
url https://www.frontiersin.org/articles/10.3389/fonc.2021.767832/full
work_keys_str_mv AT shenghuajing studyonmotionmanagementofpancreaticcancertreatedbycyberknife
AT changchenjiang studyonmotionmanagementofpancreaticcancertreatedbycyberknife
AT xiaoqinji studyonmotionmanagementofpancreaticcancertreatedbycyberknife
AT xiangnanqiu studyonmotionmanagementofpancreaticcancertreatedbycyberknife
AT jingli studyonmotionmanagementofpancreaticcancertreatedbycyberknife
AT xiangdongsun studyonmotionmanagementofpancreaticcancertreatedbycyberknife
AT xixuzhu studyonmotionmanagementofpancreaticcancertreatedbycyberknife